Renaissance Technologies LLC Reduces Holdings in Chemed Co. (NYSE:CHE)

Renaissance Technologies LLC decreased its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 1.4% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 47,100 shares of the company's stock after selling 654 shares during the period. Renaissance Technologies LLC owned 0.31% of Chemed worth $24,954,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. UMB Bank n.a. boosted its position in shares of Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new position in Chemed in the 4th quarter valued at $29,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after purchasing an additional 22 shares during the period. Trust Co. of Vermont bought a new position in shares of Chemed in the fourth quarter worth $34,000. Finally, Tortoise Investment Management LLC raised its position in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after buying an additional 34 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Trading Down 2.1 %

Shares of Chemed stock traded down $12.42 on Tuesday, hitting $588.27. 106,219 shares of the company traded hands, compared to its average volume of 97,457. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $623.61. The company has a market cap of $8.60 billion, a P/E ratio of 29.73, a P/E/G ratio of 2.15 and a beta of 0.49. The firm's 50-day simple moving average is $584.60 and its 200 day simple moving average is $567.87.

Remove Ads

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed's payout ratio is currently 10.05%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at $62,566,139.07. This trade represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 3.32% of the company's stock.

Analyst Ratings Changes

Several research firms recently commented on CHE. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada boosted their price objective on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.